# Injective EVM Expenses Methodology

## 1. Overview

Expenses measures the total cost Injective EVM incurs to operate its business, including asset incentives and operational expenditures. For this specific product, expenses are currently recorded as zero. This reflects that protocol-level costs, such as native staking rewards, are handled at the primary network layer (Injective Cosmos) rather than within the EVM-compatible execution environment.

## 2. Data sources

- **None**: This metric is set to a constant value and does not consume blockchain events.

## 3. Step-by-step calculation

### Component A: Expense identification

- **Purpose**: Identify the total costs and asset incentives attributable to Injective EVM.
- **Logic**: A value of zero is assigned to the expenses for this product. All relevant protocol incentives and inflationary rewards are captured under Injective Cosmos, as Injective EVM functions as an execution layer without independent asset issuance or operational overhead recorded in this specific context. Daily values are zero-filled to ensure consistent time-series data.

*This methodology was automatically generated by Token Terminal's methodology analyzer.*

Total project operating and incentive expenses.

Expenses

Blockchains (L1)

Validators process transactions and receive transactions fees (supply-side fees).

Injective is a smart contract platform for decentralized finance applications (a blockchain) and an orderbook exchange protocol. Injective was founded by Eric Chen, Albert Chon etc. and launched in 2020. Note that this dashboard only tracks Injective's blockchain business.

INJ holders own and govern the protocol. They currently take a cut of the total transaction fees paid by users (revenue) via Burn Auctions. Injective's investors include Binance, Jump Crypto, Mark Cuban, etc.

Injective EVM

Expenses

Expenses

Chain breakdown